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Lipopeptide biosurfactants produced by Bacillus sp. were assessed regarding their
antimicrobial activity against foodborne pathogenic and food spoilage microorganisms.
Both Gram-positive and Gram-negative bacteria were found not to be susceptible to
these lipopeptides. However, mycosubtilin and mycosubtilin/surfactin mixtures were
very active against the filamentous fungi Paecilomyces variotti and Byssochlamys fulva,
with minimum inhibitory concentrations (MICs) of 1–16 mg/L. They were also active
against Candida krusei, MIC = 16–64 mg/L. Moreover it was found that the antifungal
activity of these lipopeptides was not affected by differences in isoform composition
and/or purity. Furthermore their cytotoxicity tested on two different cell lines mimicking
ingestion and detoxification was comparable to those of approved food preservatives
such as nisin. Overall, for the first time here mycosubtilin and mycosubtilin/surfactin
mixtures were found to have high antifungal activity against food relevant fungi at
concentrations lower than their toxicity level hence, suggesting their application for
extending the shelf-life of products susceptible to these moulds. In addition combining
nisin with mycosubtilin or mycosubtiliin/surfactin mixtures proved to be an effective
approach to produce antimicrobials with broader spectrum of action.
Keywords: lipopeptides, antimicrobial, mycosubtilin, antifungal, food spoilage, nisin, B. subtilis
INTRODUCTION
According to the Food and Agriculture Organization of the United Nations (FAO), every year
around 1.3 billion tonnes of food is lost or wasted around the world, corresponding to 1/3 of all
food produced for human consumption. At the same time, it has been reported that one in nine
people globally remains malnourished (United Nations, 2019). Food losses and waste (FLW) comes
up to around 680 and 310 billion US dollars per year in industrialized and developing countries
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respectively. Fruits and vegetables, along with roots and tubers,
have the highest wastage of any food accounting for up
to 45%, meaning that almost half of fruit and vegetable
production is wasted, followed by fish and seafood (35%),
cereals (30%) and oilseeds, meat and dairy (20%) (FAO, 2020;
United Nations, 2019).
Food losses and waste can be prevented “at source,” i.e., by
the application of pesticides on agricultural products. However,
applied pesticides may enter soil and surface waters and percolate
down into groundwater, affecting biodiversity in both terrestrial
and aquatic ecosystems. Moreover, pesticide residues in food
pose a risk to animals and human health as they enter the
food chain (Gonzalez Coloma, 2018). Currently, biopesticides
are exploited as sustainable alternatives to reduce the use of
their chemical counterparts, meet the demands of the growing
population, reduce the impact on soil, air and water and improve
animals and human health. Among those, biologically active
compounds deriving from fermentation, such as biosurfactants,
can be used as the active ingredient in biopesticide and
biofungicide formulations.
Another way to tackle the problem of FLW is to extent
the shelf life of food. An area currently under investigation
is the use of bio-based packaging materials coated with
antimicrobial agents to reduce microbiological growth, also
known as “active packaging.” Antimicrobial agents that can
be used, with some being recently investigated, are essential
oils (Atarés and Chiralt, 2016; Cofelice et al., 2019), organic
acids (Cruz-Romero et al., 2013), bacteriocins (Meira et al.,
2017), natural polymers such as chitosan (Zainal Abidin et al.,
2019), and biosurfactants (Magalhães and Nitschke, 2013;
Meena and Kanwar, 2015).
Biosurfactants are surface-active-agents, produced mainly by
microorganisms as secondary metabolites. Such compounds
are amphipathic and can decrease the interfacial tension
between two immiscible liquids. As such, these compounds
are secreted by microorganisms in order to grow on or take
up hydrophobic substances (Kosaric and Vardar-Sukan, 2015;
Kourmentza et al., 2018).
Due to their amphiphilic nature, biosurfactants comprise at
least one hydrophilic moiety, such as a carbohydrate, peptide,
carboxyl group and one hydrophobic moiety, usually a fatty acid
or a fat alcohol (Jauregi and Kourmentza, 2019; Kourmentza
et al., 2019). Lipopeptide biosurfactants are cyclic structures
that consist of hydrophilic peptide sequences, of usually 7 to
10 amino acids long, while their hydrophobic moiety comprises
a C13–C18 fatty acid chain. They are mainly produced by
Bacillus or Pseudomonas species (Beltran-Gracia et al., 2017;
Ndlovu et al., 2017). Lipopeptides can be classified into different
categories depending on their amino acid cyclic sequence. For
example, lipopeptides that are produced by strains of Bacillus
subtilis fall into the categories of surfactin, iturin and fengycin
families that have a defined general structure (Jacques, 2011)
(Supplementary Figure S1).
Several studies have focused on the microbial production of
lipopeptides, by either wild type or genetically engineered strains
of Bacillus (Coutte et al., 2017, 2013). It has been reported
that lipopeptides produced by Bacillus strains exhibit various
biological activities, such as anti-fungal, anti-inflammatory, anti-
tumoral, anti-viral, and anti-platelet that makes them ideal
candidates for their application as therapeutic agents and drug
delivery systems (Meena and Kanwar, 2015; Kourmentza et al.,
2017; Meena et al., 2019). Therefore, they could potentially
outcompete their synthetic counterparts in such high-value
applications as they have the advantages of being biologically
produced in a sustainable way, using renewable resources,
while they expected to be less toxic towards humans and the
environment (Kopsahelis et al., 2018). However, there is still
insufficient knowledge on how these compounds act depending
on their structure. This kind of information would be of
significant value and provide insight into designing effective
products with targeted properties by regulating their microbial
production, depending on their final application.
Despite the fact that several studies have been published
on the production of lipopeptides, information regarding their
antifungal and antibacterial activity is limited and controversial.
This is due to the variety of methodologies being used to
determine their biological activities, as well as the different
purities of the lipopeptide compounds tested. It has to be noted
that, most of the studies make use of the crude biosurfactant
obtained after solvent extraction. Those results can be misleading
as the biological activity can be attributed to the presence of
other non-lipopeptide compounds, or those compounds may
act in synergy with lipopeptides, enabling biological activity.
Lipopeptides purification is not easy and can be very costly.
A green method by membrane ultrafiltration has been developed
by the authors for single molecules or mixtures where a
maximum purity around 90–95% can be reached particularly
with surfactin (Coutte et al., 2017). Indeed, the difficulties are
more important with mycosubtilin which interacts with protein
as reported in previous work by the authors (Jauregi et al., 2013).
High purity can be obtained using preparative chromatography
but would increase the processing cost drastically particularly,
at larger scale.
The aim of this study was to evaluate whether lipopeptides
can be used as food preservatives, extending the shelf life and
quality of food products by inhibiting microbiological growth.
Therefore, for the first time here the antimicrobial activity
of lipopeptide biosurfactants produced by B. subtilis strains,
namely surfactin, fengycin, mycosubtilin, and their mixtures at
different purities, were tested against foodborne pathogen and
food spoilage microorganisms. In addition, their cytotoxicity
was tested on two different cell lines, namely human gut
epithelial cells (Caco-2 cells) and a cell line already recommended
by EFSA to study the impact of the Bacillus sp. metabolites
(Vero SF cells from kidney epithelial cells of monkey and
evaluate their potential use in food applications. Antimicrobial
activity and cytotoxicity of lipopeptides were contrasted with
those of food grade preservatives, ethylenediaminetetraacetic
acid (EDTA) (E385) and nisin (E234), a polycyclic peptide
produced by Lactococcus lactis used in preservation of meat,
cheese and beverages which has also been incorporated in food
packaging. Moreover, samples produced at laboratory scale and
semi-industrial scale of different purity will be tested in order to
determine the effect of purity on activity.
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MATERIALS AND METHODS
Production and Purification of
Lipopeptides
Surfactin and fengycin lipopeptides were produced in shake
flasks (160 rpm) using Landy media, as previously reported
(Coutte et al., 2010a). Briefly, surfactin was produced by the
overproducing B. subtilis strain BBG131 using Landy medium
at 37◦C, pH 7.0 during 48 h. This medium was supplemented
by 16 mg/L of tryptophan and 0.1 M of MOPS to control
the pH during the culture (Coutte et al., 2010b). Fengycin
was produced by the B. subtilis strain Bs2504 (Ongena et al.,
2007) using the same conditions of surfactin production, expect
that the temperature was 30◦C and the culture time was
72 h. In these culture conditions the strains BBG131 and
Bs2504 were able to produce 1.305 ± 0.122 g/L of surfactin
and 0.256 ± 0.032 g/L of fengycin, respectively. Broth was
then centrifugated for 30 min at 8,000 g and the lipopeptides
were purified from the supernatant by two steps ultrafiltration
methods on 10 kDa membrane (using ethanol as the solvent
for the second step of ultrafiltration) including four steps of
diafiltration, as previously described by Jauregi et al. (2013). After
ethanol evaporation, lipopeptides were freeze dried to obtain
powder. The yield of this ultrafiltration purification process at
labscale was close to 90%.
Mycosubtilin and mixtures of mycosubtilin/surfactin powders
were produced and purified on demand by Lipofabrik (Villeneuve
d’Ascq, France).Mycosubtilin and the mycosubtilin/surfactin
mixtures were produced from two different strains and process
at a semi-industrial scale by Lipofabrik (a company specialized
in the production of lipopeptides). Mycosubtilin was produced
by the strain B. subtilis LBS1 and purified. The mixture
of mycosubtilin/surfactin (80:20) was produced by the strain
B. subtilis BLIP2. In both case batch cultures were done in
300 L bioreactor (designed by Lebas Industries, Lezennes, France)
containing 200 L of culture media at temperature of 30◦C during
72 h and with a pH of 7.0 regulated by adding concentrated
solution of NaOH and H3PO4. After the culture the produced
lipopeptides are purified using confidential processes. Solutions
containing mycosubtilin or mycosubtilin/surfactin mixtures are
extracted at different steps of the purification processes and
then freeze dried to obtain powders. The composition is
given in Figure 1C.
In these culture conditions the strain BLIP2 was able to
produce 0.934 g/L± 0.045 g/L of lipopeptides with a ratio of 80%
of mycosubtilin and 20% of surfactin. The strain LBS1 was able to
produce 0.754 g/L± 0.113 g/L of mycosubtilin.
Lipopeptides and Other Food
Preservatives
The lipopeptides used in this study were surfactin (S),
fengycin (F) and mycosubtilin (M) alone and mixtures of
surfactin/fengycin (S/F) and mycosubtilin/surfactin (M/S). In
addition, in order to evaluate the impact of lipopeptides purity
and composition on the antimicrobial activities, mycosubtilin as
well as M/S samples were produced and purified on demand by
Lipofabrik to obtain variation in purity and in composition (as
shown in Table 2).
Nisin (2.5%, Sigma-Aldrich, Gillingham, United Kingdom)
and EDTA alone (BioReagent, Sigma-Aldrich) were used as
reference food preservatives for antibacterial susceptibility
testing, while amphotericin B (European Pharmacopoeia
Reference Standard, Sigma-Aldrich) was used as quality
control for antifungal susceptibility testing against yeasts and
filamentous fungi.
Characterization of Lipopeptides by
Liquid Chromatography Electrospray
Ionization Tandem Mass Spectrometry
(LC-MS/MS) Analysis
All reagents were LCMS grade and from Fisher Scientific,
Loughborough, United Kingdom. Samples were dissolved in 30%
acetonitrile/70% water to 50 µg/mL and 2, 5, and 10 µL injects
were performed (the inject volumes that gave the greatest signal
to noise were analyzed) and separated on a 50× 2.1 Hypersil Gold
C18, 1.9 µM, 100 Å column (Thermo Scientific) using an Accela
HPLC system (Thermo Scientific). The mobile phases were (A)
water and (B) acetonitrile, both containing 0.1% formic acid. The
flow rate was 200 µL/min. The gradient was as follows; 0 min
40% B, 3 min 40% B, 5 min 50% B, 18 min 95% B, 19 min
95% B, 19.5 min 40% B, 25 min 40% B. The outlet went to a
UV detector measuring absorbance at 214, 254, and 280 nm and
from there into an LTQ-Orbitrap XL mass spectrometer (Thermo
Scientific) operating in positive ion mode. Scan event 1 was a
full scan at 100,000 resolution in the range 200–2,000 m/z. Scan
event 2 fragmented Ions of significant intensity within the LTQ
ion trap and then passed them into the Orbitrap for measurement
at 15,000 resolution. Phthalate (413.266230 m/z) was used as an
internal lock-mass.
Theoretical masses of mycosubtilin and surfactin isoforms
were calculated and extracted ion chromatograms for these were
generated accordingly. The relative areas of these isoforms in
each sample were apportioned as a % and comparisons were
made between samples. It has to be noted that this approach does
provide absolute quantitation, as different isoforms may ionize
with different efficiencies and the lack of pure isolated standards
makes a standard curve generation impossible. Nonetheless, this
approach was used for performing a relative comparison between
samples of relative amounts of isoforms within each sample.
Fengycin was produced by Bacillus strain Bs2504 as in
our previous work (Hamley et al., 2013) where results of MS
analysis can be found.
Antibacterial Susceptibility Testing of
Lipopeptides
The antibacterial susceptibility testing was performed following
the broth microdilution methodology, as described previously
(Schwalbe et al., 2007), against both Gram-negative and Gram-
positive foodborne pathogens and spoilage bacteria. The bacteria
used were: Pseudomonas aeruginosa NCTC 10332, Salmonella
enterica NCTC 5188, Escherichia coli K-12, Bacillus cereus MR59,
Listeria monocytogenes 10403S, Carnobacterium divergens NCFB
Frontiers in Microbiology | www.frontiersin.org 3 January 2021 | Volume 11 | Article 561060
fmicb-11-561060 December 29, 2020 Time: 17:4 # 4
Kourmentza et al. Antimicrobial Activity and Cytotoxicity of Lipopeptide Biosurfactants
FIGURE 1 | Relative abundance of (A) mycosubtilin isoforms in different mycosubtilin samples, (B) of mycosubtilin isoforms, and (C) surfactin isoforms in different
M/S samples.
2763, Leuconostoc mesenteroides NCIMB 08023, and Brochothrix
thermosphacta NCDO 1676. Moreover, for comparison, along
with lipopeptides, nisin and EDTA were also tested. Nisin is a
polycyclic antibacterial peptide produced by Lactococcus lactis
and is an approved food preservative while EDTA is used for the
control of microorganisms and biofilms (Finnegan and Percival,
2015; Vessoni Penna et al., 2005).
Since purified lipopeptides and lipopeptide mixtures have low
solubility in water they were dissolved in 1% dimethyl sulfoxide
(DMSO) and further diluted in the test medium Muller-Hinton
(MHB), or Tryptone Soy Broth (TSB) which was alternatively
used for C. divergens, L. monocytogenes, L. mesenteroides, and
B. thermosphacta. Two-fold dilutions were performed and 100 µL
of each dilution was placed in each column of a flat bottomed 96-
well plate. One column of the plate contained only the growth
medium and served as the positive control while in another
column contained 200 µL of the growth medium with the highest
concentration of the lipopeptide tested (1,000 mg/L) and served
as the negative control. Apart from the column that served
as the negative control, the rest of the wells were inoculated
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with 100 µL of the bacterial culture tested. For the bacterial
suspension preparation, cultures were incubated overnight in
the appropriate medium (MHB or TSB). Bacterial density was
adjusted to 0.5 McFarland and suspensions were subsequently
diluted 1000 times using the growth test medium. The 96-well
plates were then incubated at either 30or 37◦C, depending on
the optimal growth temperature of each microorganism, for
24 h and the OD620nm was assessed. The minimum inhibitory
concentration (MIC) was defined as the lowest concentration
of the antimicrobial agent tested that prevented any discernible
growth after 24 h incubation.
For testing the antibacterial activity by combining nisin and
lipopeptides, the broth microdilution assay described above was
used, following the broth microdilution checkerboard panel
(Schwalbe et al., 2007).
Antifungal Susceptibility Testing of
Lipopeptides Against Yeasts
The antifungal susceptibility test against yeasts was performed
according to the broth microdilution method, as described
previously (Urbañski et al., 2002; Schwalbe et al., 2007). Candida
krusei ATCC 6258 was used as the quality control organism,
to verify that antifungal concentrations were prepared properly.
In addition, amphotericin B, an effective antifungal antibiotic
produced by Streptomyces nodosus and part of the WHO List
(World Health Organization) of Essential Medicines, was used
as a reference compound. The test medium used was RPMI-
1640 (with glutamine, without bicarbonate and with a pH
indicator) broth with [3-(N-morpholino)]-propanesulfonic acid
(MOPS) buffer. All tests were performed in U-shaped 96-well
plates. Three technical replicates of each assay were carried
out on the same day with the same culture and chemical
compound with the aforementioned experiment repeated also
in triplicate on different days using different cultures (biological
replicates) resulting in a total of nine replicates for each assay.
The yeasts tested were Zygosaccharomyces bailli NCYC 464 and
Debaryomyces hansenii NCYC 102.
However, due to poor growth of the selected yeasts in
the RPMI-1640 medium agar, dilution susceptibility testing
was also performed as previously described (Schwalbe et al.,
2007) with some modifications. Malt extract agar (MEA) was
used as growth medium supplemented with lipopeptides at
concentrations ranging from 2 to 264 mg/L. Ten µl of yeast
inocula, with 105–102 CFU/mL, were placed on the agar surface
and their growth was monitored after 24 and 48 h of incubation
at 30◦C.
Antifungal Susceptibility Testing of
Lipopeptides Against Filamentous Fungi
The antifungal susceptibility testing of lipopeptides against
filamentous fungi was performed according to the broth
microdilution methodology, as described previously (Schwalbe
et al., 2007). In this set of experiments, Candida krusei ATCC
6258 and amphotericin B were used to perform quality control
tests for validation. As mentioned above, the test medium used
was RPMI-1640 broth with MOPS buffer. Tests were performed
in U-shaped 96-well plates in triplicates and the OD450nm was
recorded after 7 days of incubation at 30◦C. The fungi tested
were Rhizopus stolonifer IMI 017314 and Paecilomyces variotii
and Byssochamys fulva IMI 040021.
Cytotoxity Assays
Cytotoxicity studies were carried-out with the three lipopeptides
alone and mixtures of them with nisin and EDTA as food
preservative controls on two different cell lines, the Caco-2
cells (human epithelial cells from gut) and the Vero SF cells
(monkey epithelial cells from kidney). The Vero SF cells line
is recommended by EFSA to assess the toxigenic potential of
Bacillus species used in animal nutrition (EFSA, 2014). Cells were
cultured in Dulbecco’s modified Eagle’s medium supplemented
with 10% FCS, 1% glutamine, and 1% penicillin-streptomycin.
After 48 h, cell culture medium was replaced by fresh medium
containing the tested compounds in various concentrations.
Cytotoxicity was determined through a commercial kit
from SIGMA Aldrich (Saint-Louis, United States) named Cell
Counting kit 8 (CCK8). This test is based on the water-soluble
tetrazolium salt (WST-8) reduction by the dehydrogenase of
the living cells only inducing the production of a yellow color
formazan dye which is directly proportional to the number
of cells. Twenty-four hours after addition the compounds,
the WST-8 was added to the medium (100 µL/mL). After
2h incubation, absorption at 650 nm was measured in
a microplate-reader (Microplates reader SpectraMax R© iD3,
Molecular Devices, San Jose, United States) and values were
expressed as percent of control. The half maximal inhibitory
concentration (IC50) was been determined, in agreement with the
FDA standard, as the potency of a compound to inhibit 50% of
the cell growth.
As explained above, since some of the lipopeptides have
limited solubility in aqueous solutions, prior to their cytotoxicity
testing, the effect of the DMSO at the levels used to solubilize
the lipopeptides, was assessed. DMSO at high concentrations is
known to inhibit cell growth, therefore, the DMSO tolerance of
each cell line was examined in order to determine a maximum
final percentage of 10% DMSO in the culture medium (data
not shown).
Each compound was solubilised in a mix of water/DMSO
5% at different concentrations ranging from 2 mg/L to
5 g/L. The compounds tested were mycosubtilin (M-I),
surfactin and fengycin as well as different mixtures such as
mycosubtilin/surfactin (M/S-I), fengycin/surfactin. Water and
DMSO 5% were used as a control. Nisin and EDTA were used
between 100 mg/L and 10 g/L.
Statistical Analysis
For the antimicrobial (antibacterial and antifungal) tests three
technical replicates of each assay were carried out on the
same day with the same culture and chemical compound with
the aforementioned experiment repeated also in triplicate on
different days using different cultures (biological replicates)
resulting in a total of nine replicates for each assay. Results are
reported normally as range of the multiple MIC determinations
while when all determinations showed one MIC, this value is
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TABLE 1 | MICs obtained for nisin and EDTA against the bacterial strains studied.
Bacterial strain Nisin (mg/L) EDTA (mg/L)
Gram-negative bacteria
P. aeruginosa NTCT 10332 >107.3 7,306
S. enterica NCTC 5188 >107.3 14,612
E. coli K-12 >107.3 14,612
Gram-positive bacteria
L. monocytogenes 10403S 6.71 227.94
B. cereus MR59 6.71 227.94
C. divergens NCFB 2763 3.35 55.58
L. mesenteroides 1.68 114.01
B. thermosphacta 0.20–0.10 114.01
reported. The upper and lower values denote the limits all values
fall within.
For the cytotoxicity study six technical replicates for each
concentration were carried out in the same experiment which
was replicated three times. Means values of all the replicates
and standard deviation are presented while a Student test was
applied to identify statistically significant differences with nisin
used as reference.
RESULTS AND DISCUSSION
All MICs results were highly reproducible with all nine replicates
giving the same value within a range of two successive dilutions.
Antibacterial Activity of Food
Preservatives
As mentioned above, tests were performed in order to examine
the antibacterial activity of nisin (E234) and EDTA (E385) on
the selected bacterial strains, which are associated with food
spoilage. According to the results obtained, as shown in Table 1,
the maximum concentrations of nisin and EDTA used were up
to 107.3 mg/L (32 µM) and 29.2 g/L (100 mM) respectively.
Nisin alone was only effective against Gram-positive bacteria
with MICs ranging between 0.1 and 6.7 mg/L. Among Gram-
positive bacteria, B. thermosphacta was the most susceptible to
nisin (MIC = 0.10–0.20 mg/L) followed by L. mesenteroides
(MIC = 1.68 mg/L), C. divergens (MIC = 3.35 mg/L), B. cereus
and L. monocytogenes (MIC = 6.71 mg/L). These results
are in agreement with the literature, since nisin is mainly
active against Gram-positive bacteria at concentrations ranging
between 1 and 25 mg/L (Zhou et al., 2014, 2016). Nisin has
relatively low activity against Gram-negative bacteria since it
has difficulty in penetrating the outer membrane that acts as
a barrier to its action on the cytoplasmic membrane, which
is its main target (Li et al., 2018). Due to the presence of
magnesium ions, which play a role in the stabilization of
the lipopolysaccharide layer in the outer membrane, chelating
agents such as EDTA can facilitate nisin’s action by binding
to magnesium ions in the lipopolysaccharide layer and in
this way increase susceptibility to antibiotics and detergents
(Lambert et al., 2004).
When EDTA was used on the selected bacterial strains,
the MICs for Gram-positive bacteria ranged between 0.19 and
0.78 mM (55.58–227.94 mg/L) while these for Gram-negative
bacteria were much higher, ranging between 25 and 50 mM
(7,306–14,612 mg/L). EDTA is normally used as a preservative
in ocular preparations and eye drops and also as a slime
dispersant as it inhibits adherence of strains in intraocular lenses
(Kadry et al., 2009). As mentioned above, EDTA is a chelating
agent used to destabilize the outer membrane of Gram-negative
bacteria allowing antimicrobial agents, such as nisin, quaternary
ammonium surfactants, oxacillin, cefamandole, etc., to be more
efficient inhibiting their growth (Field et al., 2017; Li et al., 2018).
Antibacterial Activity of Lipopeptides
Since some lipopeptides have limited solubility in aqueous
solutions, prior to their antibacterial testing the effect of the
DMSO at the levels used to solubilize the lipopeptides, was
assessed. DMSO at high concentrations is known to inhibit
microbial growth, therefore, the DMSO tolerance of each strain
was examined. The maximum concentration tested was up to 8%
DMSO and the growth of the bacterial strains was monitored
by checking the OD620nm of the bacterial suspension after 24 h.
Our results indicated that DMSO concentrations below 1%, had
no inhibitory effect on the bacterial growth of all strains tested.
The maximum concentration of lipopeptides tested was up to
1,000 mg/L in the presence of 1% DMSO.
Most of the lipopeptides had no effect on the growth of
the bacteria tested (i.e., P. aeruginosa, S. enterica, E. coli,
L. monocytogenes, B. cereus, and L. mesenteroides). However,
unexpected results were obtained for the Gram-positive bacteria
C. divergens and in particular, B. thermosphacta, with some
samples (batches) of mycosubtilin and mycosubtilin/surfactin
mixture (Table 2). MICs for C. divergens were found to be
500 mg/L for mycosubtilin I (M-I) and mycosubtilin/surfactin I
(M/S-I). The same samples were active against B. thermosphacta,
as MICs of 15.6 and 62.5 mg/L were obtained for M-I and
M/S-I respectively. Since surfactin alone did not show any
antimicrobial activity the activity of the mixture M/S was
attributed to mycosubtilin. However, the MIC values of the
latter are extremely high even in comparison with other natural
antibacterial molecule such as nisin which inhibits the growth
of B. thermosphacta and C. divergens with a MIC of 0.15 and
3.35 mg/L, respectively (Table 1). These values are 100 to 200 fold
lower than those obtained with sample containing mycosubtilin.
So, in order to understand what could lead to the
variation in the antibacterial activity of mycosubtilin and
mycosubtilin/surfactin samples from different batches two
hypothesis were drawn: (i) there is a correlation between
mycosubtilin’s isoforms composition and its activity against these
two bacteria (ii) the antibacterial activity is exerted by other
antibacterial compounds in the samples which are coproduced
with lipopeptides by B. subtilis.
In order to test the first hypothesis, the isoform composition
of mycosubtilin and mycosubtilin/surfactin samples were
compared. The LC/MS analysis (Figure 1) show that
mycosubtilin isoforms consisted of fatty acid chains of 15
to 18 carbon atoms (C15–C18) (see Supplementary Table S1 for
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TABLE 2 | MICs of lipopeptides against the Gram-positive bacteria C. divergens and B. thermosphacta.
Lipopeptide Composition Purity MIC (mg/L)
(%) (%) C. divergens B. thermosphacta
Surfactin (S) 92 >1,000 >1,000
Fengycin (F) 84 >1,000 >1,000
Mycosubtilin I (M-I) 81 500 15.6
Surfactin/Fengycin (S/F) 46:54 72 >1,000 >1,000
Mycosubtilin/Surfactin I (M/S-I) 80:20 >80 500 62.5
Mycosubtilin II (M-II) >80 >1,000 125
Mycosubtilin III (M-III) >80 >1,000 >1,000
Mycosubtilin IV (M-IV) 89 >1,000 >1,000
Mycosubtilin/surfactin II (M/S-II) 80:20 >80 >1,000 125
Mycosubtilin/surfactin III (M/S-III) 80:20 61 >1,000 >1,000
Mycosubtilin/surfactin (M/S-23%) 80:20 23 >1,000 15.6
Mycosubtilin/surfactin (M/S-34%) 80:20 34 >1,000 >1,000
Mycosubtilin/surfactin (M/S-42%) 80:20 42 >1,000 >1,000
M-I, Nov17; M-II, March18; M-III, July18; M-IV, Oct18; M/S-I, Nov17; M/S-II, March18; M/S-III, Oct18.
detailed composition data). The relative abundance of isoforms
was similar for samples M-III and M-IV and none of these
samples showed antibacterial activity (Figure 1A). On the other
hand, samples M-I and M-II had different isoform composition
and were particularly active against B. thermosphacta. In
particular, M-II had the highest proportion of C17 isoform
(78%) of all samples, but it was at similar proportion in M-I
as in M-III and M-IV. Furthermore, M-I had the highest
proportion of C18 isoform of all samples (15%). Moreover, the
comparison of isoform composition of mycosubtilin in M/S
mixtures (Figure 1B) showed that MS-I and M/S-II presented
the highest proportion of C18 (≥10%) and C17 (≥74%)
isoforms respectively, and display activity (MIC = 15.6 and
125 mg/L, respectively) against B. thermosphacta. Nevertheless,
M/S III, M/S-34% and M/S-42% which had similar profile
of C17 isoform and C18 isoform were not active against
B. thermosphacta.
A few studies have examined the antibacterial activity of
purified lipopeptide homologues against microorganisms and
showed that MICs obtained were different as per homologue.
For example, C14, C15, and C16 iturin had an MIC of
60, 30, and 7.5 mg/L, respectively, against Candida albicans.
For Micrococcus flavus and Escherichia coli, iturin homologues
had no effect on their growth. On the other hand, surfactin
homologues C14, C15, and C16 showed MICs of 30, 15, and
1.88 mg/L, respectively. In addition, C15 and C16 homologues
showed MICs of 60 and 3.75 mg/L, respectively against E. coli
(Dhanarajan et al., 2016).
From the results of the present study, it was concluded
that despite of the differences in the relative abundance of
the isoforms there was no conclusive evidence correlating the
antibacterial activity with the composition of individual isoforms.
So, we could reject the first hypothesis. Another hypothesis
and plausible explanation for the variation in activity between
different batches was that the antimicrobial activity might
be attributed to impurities present in certain samples which,
accounted for more than 10 % in each mycosubtilin sample.
For example, it has been reported that genes for antimicrobial
dipeptides, such as bacilysin, as well as genes for another
lantibiotic very active against gram positive bacteria, subtilin
and subtilosin A, were present in 93% of the strains (Harwood
et al., 2018). Moreover, it is known that the strains used
in this study have the ability to produce these antibacterial
molecules (Parisot et al., 2008; Fickers, 2012; Velho et al., 2013).
The main problem with these peptides is their low stability,
in fact they can degrade quickly in the culture medium of
B. subtilis or during the purification process (Kuboi et al.,
1994). This may therefore explain their presence or not in
certain of our samples with low purity. Interestingly, this activity
was only observed in the batch samples of mycosubtilin (or
mycosubtilin/surfactin) produced and purified until March 2018
and not after this date, this period coincides with a change
in the purification process of mycosubtilin (confidential data).
So, the hypothesis of active impurities purified at the same
time as lipopeptides seems to make sense. This theory is
supported by the result obtained with high resolution mass
spectrometry analysis performed with the sample M-I, using
the methodology described by Omoboye et al. (2019) and
presented in Supplementary Figure S2. This analysis reveals
the presence of two peaks, one at m/z = 830 and another one
at 1,107. The one at 1,107 corresponds to mycosubtilin C17
which is the more abundant isoform in this sample (Figure 1)
and the one at 830 correspond to the quadricharged ions
of subtilin, which gave a total mass of 3,320. All of these
results allow us to conclude that the antibacterial activity
observed against B. thermosphacta is absolutely not due to
lipopeptides but rather to the presence of another compound
such as subtilin.
Similarly, in the literature when the antibacterial activity of
crude lipopeptides is reported other bioactive compounds may
be responsible for this activity and it cannot be directly attributed
to the presence of lipopeptides.
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TABLE 3 | MICs (mg/L) obtained for lipopeptides against yeasts grown (at 102–103 CFU/mL) on malt extract agar.
Lipopeptide Composition Purity C. krusei* Z. bailii** D. hansenii*
(%) (%)
Surfactin (S) 92 >256 > 256 > 256
Fengycin (F) 84 >256 > 256 > 256
Surfactin/Fengycin (S/F) 46:54 72 >256 > 256 > 256
Mycosubtilin III (M-III) >80 32 > 256 >256
Mycosubtilin/Surfactin (M/S-I) 80:20 >80 16 8 128
Mycosubtilin/surfactin II (M/S-II) 80:20 >80 8 8 128
Mycosubtilin/surfactin III (M/S-III) 80:20 61 >256 > 256 128
*MIC recorded after 24 h of growth.
**MIC recorded after 48 h of growth.
Antifungal Activity of Lipopeptides
Against Yeasts
In these tests, lipopeptides activity was investigated against the
food spoilage relevant yeasts C. krusei, D. hansenii, and Z. bailii.
For these tests, the yeast C. krusei was used as the reference strain
and amphotericin B was used as positive control. According
to the obtained results for tests performed in liquid media,
mycosubtilin and the M/S samples showed antifungal activity
with MICs of 16 and 32–64 mg/L, respectively, after 24 h of
growth (Supplementary Table S2). The MIC of mycosubtilin or
M/S samples remained similar after 48 h of growth except for
the sample M-I, whose MIC increased to 64 mg/L after 48 h.
Overall these results show consistent anti-yeast activity as no
variation between batches (with different isoform composition)
was observed in this case.
Due to poor growth of the yeasts D. hansenii and Z. bailii
in liquid media, susceptibility tests were performed using MEA
agar plates, where lipopeptides were incorporated. The growth
of all yeasts, including C. krusei, was monitored for different cell
concentrations (102–105) and MICs were recorded after 24 h of
growth for C. krusei and D. hansenii and after 48 h for Z. bailii,
as it is a slower growing yeast (Table 3). In agreement with
results obtained by the microdilution method (Table 3) only
mycosubtilin and the M/S samples showed antifungal activity and
similar MIC values were obtained within the range of 8–32 mg/L
(Table 3). No MIC was observed for M/S-III, but this sample was
active against the yeast D. hansenii (MIC = 128 mg/L). All the M/S
mixtures were active against the D. hansenii with the same MIC
(128 mg/L), whereas all samples but MS-III were active against
Z. bailli with a MIC of 8 mg/L.
Surfactin is known to have a concentration-dependent
mode of action, inducing limited perturbation, such as pore
formation, at low concentrations (Heerklotz and Seelig, 2007).
In all experiments performed in this study, no antimicrobial
activity was observed when surfactin was individually used at
concentrations up to 1000 mg/L whilst mycosubtilin was very
active against C. krusei. However, the M/S mixture was slightly
more active against C. krusei and only the M/S mixture showed
activity against the other two yeasts. Synergistic activities of M/S
samples have been already reported for phytopathogenic fungi,
such as F. oxysporum (Mihalache et al., 2017) and B. lactucae
(Deravel et al., 2014), and it is also known that anionic and
non-ionic biosurfactants, when combined, form mixed micellar
structures that act more efficiently on biological membranes than
simple micelles (Jauregi et al., 2013; Deravel et al., 2014).
In general, mycosbtilin is characterized by strong antifungal
activity against yeasts such as Candida albicans, Candida
tropicalis, Candida glabrata, Cryptococcus neoformans, Pichia
pastoris, Saccharomyces cerevisiae, and Yarrowia lipolytica,
among others (Nasir and Besson, 2012). Mycosubtilin belongs
to the iturin family, and these biosurfactants are known to
increase membrane cell permeability due to the formation of
ion-conducting pores, with their characteristics depending on
lipid membrane composition and the peptide cycle structure.
It has been suggested that ionic pores are attributed to
lipopeptide or lipopeptide/phospholipid complex aggregates
in the phospholipid membrane (Maget-Dana and Peypoux,
1994; Desmyttere et al., 2019). A study investigating in vitro
susceptibilities of the abovementioned yeasts to purified anteiso-
C17 mycosybtilin homologue showed MIC ranging between 2
and 150 mg/L (Fickers et al., 2009), which are within the range
of MICs observed in this study. This is the first time that
the activity of lipopeptides has been tested against C. krusei,
a species involved in chocolate production and an emerging
fungal nosocomial pathogen for patients with hematologic
malignancies and for transplant recipients, which served also
as the quality control. Moreover, lipopeptide susceptibility test
against Z. bailli and D. hansenii were reported here for the
first time. Z. bailii is one of the most troublesome species for
the food industry since spoilage occurring from its growth is
quite widespread due to its tolerance to various stress conditions.
It is an effective spoiler of several foods and beverages with
low pH and high sugar content, such as fruit concentrates,
wines, soft drinks, syrups, etc. causing significant economic
losses to the food industry (Kuanyshev et al., 2017). On
the other hand, Debaryomyces hansenii, is an osmo-, halo-
and xerotolerant species, common in all types of cheese and
the most common yeast in unsulfited and sulfited sausages,
skinless sausages and minced beef (Breuer and Harms, 2006).
The fact that those species are susceptible to mycosubtilin
and M/S lipopeptides enables the use of these lipopeptides as
sustainable and low toxicity antifungal agents in food-related
and biomedical applications, to restrict the growth of specific
fungal pathogens.
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TABLE 4 | MICs obtained for lipopeptides against filamentous fungi after 7 days of growth in RPMI-1640 liquid media.
Lipopeptide Composition Purity R. stolonifer P. variotii B. fulva
(%) (%) MIC (mg/L)
Amphotericin B 0.5 0.06 0.06
Surfactin (S) 92 >64 >64 >64
Fengycin (F) 84 >64 >64 >64
Mycosubtilin (M-I) 81 >64 2 2
Surfactin/Fengycin (S/F) 46:54 72 >64 >64 >64
Mycosubtilin/Surfactin (M/S-I) 80:20 >80 >64 2 2
Mycosubtilin III (M-III) >80 >64 2 2
Mycosubtilin IV (M-IV) 89 >64 2 2
Mycosubtilin/surfactin II (M/S-II) 80:20 >80 >64 1 1
Mycosubtilin/surfactin III (M/S-III) 80:20 61 >64 4 4
Mycosubtilin/surfactin (M/S-23%) 80:20 23 >64 8–16 8–16
Mycosubtilin/surfactin (M/S-34%) 80:20 34 >64 8–16 8–16
Mycosubtilin/surfactin (M/S-42%) 80:20 42 >64 8 8
Antifungal Activity of Lipopeptides
Against Filamentous Fungi
In this study lipopeptides were tested against food
spoilage/pathogen relevant filamentous fungi: (i)
Rhizopus stolonifer which is commonly known as
black bread mold, (ii) Paecilomyces variotii, a heat-
resistant fungi and common contaminant in heat
treated foods and juices, and (iii) Byssocchlamys fulva,
which is a soil plant pathogen affecting strawberries,
pineapples and other fruits and can be also found in
pasteurized juices.
According to the results obtained, R. stolonifer was not
susceptible to any of the lipopeptides tested, at concentrations
up to 64 mg/L (Table 4). This is in accordance with the
literature, as it has been reported recently that the growth
of R. stolonifer is only inhibited at higher concentrations
of iturin (100 mg/L), fengycin (150 mg/L), and surfactin
(200 mg/L) (Liu et al., 2014). On the other hand, P. variotii
and B. fulva were susceptible to all mycosubtilin and M/S
samples tested. MICs obtained for any of the mycosubtilin
samples were at 2 mg/L and MICs for M/S samples of
high purity (>80%) ranged between 1 and 2 mg/L, whereas
M/S samples of lower purity (23–61%) showed MICs of
4–16 mg/L. Once again, the activity was not dependent
on the isoforms composition (batch) and/or purity of
the sample.
This is the first report on the effect of lipopeptides
on the growth of P. variotii and B. fulva, with results
being similar to those reported in the literature for other
fungal strains. For example, when mycobubtilin and M/S
(50% w/w) were tested against Fusarium oxysporum MICs
were 10 and 5 mg/L, respectively, while surfactin showed
no inhibition at concentrations up to 500 mg/L (Mihalache
et al., 2017). In another study, half maxima inhibitory
concentrations for mycosubtilin and M/S (50% w/w) against
Zymoseptoria tritici were 1.4 and 4.5 mg/L, respectively
(Mejri et al., 2017).
Antimicrobial Activity of
Nisin-Lipopeptides Combinations
Since lipopeptides did not clearly demonstrate an effect on
the growth of bacteria, the combination of nisin with the
active lipopeptides was examined against C. divergens and
filamentous fungi.
A shown in Figure 2, the combination of nisin with
mycosubtilin (M-I) had no effect on the MICs obtained for each
individual compound, suggesting no synergistic nor antagonistic
effects. It must be noted that the mycosubtilin sample tested
here (M-I) showed antimicrobial activity (MIC = 500 mg/L)
whereas other samples did not (see above), as explained above,
this may be due to other antimicrobials in the sample which
have not been identified. In any case, these results show
that combining nisin with mycosubtilin did not affect the
antimicrobial activity of nisin which was very effective against
C. divergens (MIC = 1 mM = 3.35 mg/L). These results were
confirmed when mixing 10 mg/L nisin with mycosubtilin (M-IV)
at same range of concentrations as in Figure 2. Mixing of nisin
at 10 mg/L with mycosubtiliin up to 500 mg/L led to complete
inhibition of bacterial growth (data not shown). The same was
observed when nisin was mixed with the mycosubtilin:surfactin
mixture (M/S-III).
When nisin was combined with surfactin, at the same
range of concentrations as mycosubtiliin, neither synergistic
nor antagonistic effects were observed as the MIC obtained
for C. divergens was the same as for nisin alone (3.35 mg/L),
regardless of the surfactin concentrations (data not shown).
The same mycosubtlin (M-IV) and M/S (M/S-III) samples
were combined with nisin (Table 5) to test antifungal
activity. Nisin alone showed no inhibition of P. variotii and
B. fulva at concentrations up to 125 mg/L. Furthermore when
combined with mycosubtilin or MS at a fixed concentration
(10 mg/L) the MIC values obtained were the same as
those for mycosubtilin or mycosubtilin:surfactin mixture alone
(Table 5). Thus, no synergistic or antagonistic effect was
conferred by nisin.
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FIGURE 2 | OD620nm of C. divergens after 24 h of growth in a broth microdilution checkerboard panel containing nisin (0.039–8 µM or) and mycosubtilin (M-I,
7.8–1,000 mg/L).
TABLE 5 | Antifungal activities of nisin and combinations with lipopeptides.
Compound(s) C. krusei R. stolonifer P. variotii B. fulva
Lipopeptide MIC (mg/L)
Nisin, >125 >125 >125 >125
Nisin + M-IV 16 >64 2 2
Nisin + M/S-III 64 >64 4 4
M-IV 16 >64 2 2
M/S-III 64 >64 4 4
MICs (mg/L) of nisin, lipopeptides alone and combinations with nisin at a fixed
concentration of 10 mg/L).
These are very interesting results which demonstrate
that by combining nisin with mycosubtiliin or M/S a
combined antimicrobial activity can be achieved which
broadens the spectra of action, i.e., activity against both
Gram-positive bacteria (susceptible to nisin) and fungi
(susceptible to M and M/S).
Cytotoxicity of Lipopeptides Produced
by B. subtilis
According to the results obtained, lipopeptides showed different
levels of cytotoxicity. To put into perspective, the lipopeptide’s
values have been experimentally compared against the food
preservatives nisin (E234) and EDTA (E386) which are
authorized in Europe by EFSA and graded as GRAS by
the FDA. As shown in Figure 3, EDTA (E386) showed no
cytotoxicity towards the two cell lines tested, and always
exhibited the highest IC50. Mycosubtilin was the lipopeptide
with the lowest IC50 on the two cell lines (between 10 and
20 mg/L), but it was three times less cytotoxic than the food
additive nisin (E234) on Caco-2 cells (Figure 3B). Moreover,
the different lipopeptides, alone or as a mixture, were less
cytotoxic on Caco-2 cells compared to the food grade additive
nisin (E234) (Figure 3B). However, toxicity against Vero cells
showed that only fengycin, surfactin and their mix were
less cytotoxic than nisin (E234) (Figure 3A). Moreover, it is
important to highlight that the IC50 values of mycosubtilin and
mycosubtilin/surfactin mixtures were largely above their MIC
against filamentous fungi (1–2 mg/L) (Table 4). In a similar
fashion, nisin’s IC50 (even against Caco-2 cells) was above its
MIC against Gram-positive bacteria (Table 1). The estimated
IC50 of the lipopeptides and nisin (E386) determined in these
experiments (cytotoxicity MTT assays on undifferentiated Caco-
2 and Vero cells with 24 h of contact) were then compared to
already published IC50 values (using a similar protocol to ours)
of others preservatives/antioxidants food additive molecules
or food packaging additive molecules. The choice of these
molecules was made based on available data and by taking
representative molecules from each category of food additives
or food packaging additive molecules (antimicrobial peptides,
synthetic antioxidant, chemical preservative, plant extract and
essential oil, and nanoparticles) (Figure 4). Nanoparticles have
drawn recently great interest due to their various properties
(barrier properties, antimicrobial properties, etc. . .) that make
them advantageous in food and food packaging applications
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FIGURE 3 | In vitro cytotoxicity of different lipopeptides after 48 h of incubation and representation of their half-maximal inhibitory concentration (IC50) against
(A) Vero-SF cells and (B) Caco-2 cells. Data are shown as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
(Bumbudsanpharoke et al., 2015), that’s why it seemed necessary
to add them here. Data of these preservatives/antioxidants
such as formaldehyde (E240) (Marcsek et al., 2007; Boncler
et al., 2019), Salvia rosmarinus extract (E392) (Aherne et al.,
2007; Waller et al., 2016), butylhydroxyanisol (BHA) (E320)
(Labrador et al., 2007) and biological extracts such as carvacol
(the main component of many essential oil) (Llana-Ruiz-
Cabello et al., 2014; Mooyottu et al., 2014), iturin A (another
antifungal lipopeptide produced by B. subtilis) (EFSA Panel
on Additives and Products or Substances used in Animal
Feed [FEEDAP], 2017; Zhao et al., 2018), Thymus vulgaris oil
extract (Pérez-González et al., 2019) and nanoparticles such
as ZnO NP (Song et al., 2014; Venkateasan et al., 2017)
and Ag NP (Song et al., 2014; Kumar et al., 2017) have
been collected from literature. In conclusion, as shown in
Figure 4, lipopeptides had low toxicity on human cell lines.
In fact, the in-vitro test against these cell lines simulated the
detoxification by the kidney (Vero SF cells), as well as ingestion
and absorption by the intestine (Caco-2 cells). It has to be
noted that few reports, published recently, have studied the
IC50 of lipopeptides in this context. In these studies, the IC50
of iturin A was estimated between 28 mg/L (Zhao et al., 2019)
and 42 mg/L (Zhao et al., 2018) on Caco-2 cells around
16 mg/L on Vero cells (EFSA Panel on Additives and Products
or Substances used in Animal Feed [FEEDAP], 2017) which
corresponded to the range of values obtained with mycosubtilin
in this study. When we compare lipopeptides and in particular,
mycosubtilin with other molecules used in the food industry
with antimicrobial and/or antioxidant activity we observe a very
acceptable cytotoxicological profile. According to the results on
these two cell lines it is possible to distinguish three groups:
For Caco cells, group 1 of molecules with low cytotoxicity,
IC50 above 100 mg/L (fengycin, surfactin, Ag nanoparticules,
rosemary extract (E392)), group 2 with moderate cytotoxicity
with IC50s between 10 and 100 mg/L (carvacol, iturin A, and
mycosubtilin) and finally group three with significant cytotoxicity
with IC50 lower than 10 mg/L (nisin (E234), formaldehyde
(E240), thyme extract, ZnO nanoparticles); for Vero cells,
group 1 (fengycin, surfactin, rosemary extract (E392), and nisin
(E234)), group 2 (ZnO nanoparticles, carvacol, iturin A, and
mycosubtilin); group 3 (BHA (E320), Ag nanoparticles, and
formaldehyde (E240)). Overall these results are encouraging,
and although further tests will need to be carried out, they
suggest that lipopeptides can be safe to use in food applications
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FIGURE 4 | Comparative histograms presenting the estimated IC50 (in mg/L) of the tested lipopeptides (black columns) compared to the IC50 of other active
preservatives/antioxidant molecules (light gray columns) using MTT assay on (A) Caco-2 cells and (B) Vero cells after 24 h of contact, except for molecules with
asterisks where the contact time was 48 h (data originated from EFSA database and literature review).
such as food packaging at the concentrations that they exhibit
antifungal activity.
CONCLUSION
Lipopeptides had no antimicrobial activity against the food
spoilage bacteria tested. Some samples of mycosubtilin and
M/S mixture from the same two batches showed activity,
particularly against B. thermospacta however, this activity was
not reproduced with samples from other batches; most likely,
as we demonstrated in this work, the activity could be
attributed to other antimicrobials produced by B. subtilis such
as, subtilin. Mycosubtilin and M/S samples showed for the
first time strong antifungal activity, against food-related fungi
despite their isoform composition and purity, with MICs of 1–
16 mg/L. Interestingly they were not toxic at those concentrations
when tested on a range of human cell lines here for the
first time. Furthermore, these lipopeptides present cytotoxicity
comparable to already marketed food additives suggesting their
possible novel use in food applications. Finally, combinations
of nisin and mycosubtilin or nisin and mycosubtilin/surfactin
were found to be active against both bacteria and fungi
with activities similar to those of the individual components.
These are very interesting and novel results which can lead
to the development of combined antimicrobials with broader
spectrum of action and low toxicity showing potential as
new food additives.
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